Benitec Biopharma Inc. (NASDAQ:BNTC) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock Update: US$13.5 a share · Leerink Partners +2 Dealers: Leerink Partners (co-lead), TD Cowen (co-lead), Evercore ISI (co-lead) Use of proceeds: Continued development of product candidate programs, working capital and general corporate purposes | Nov 6, 2025 |
| Registered direct offering of common stock Update: US$13.5 a share · Leerink Partners +2 Dealers: Leerink Partners, TD Cowen, Evercore ISI Buyers: Suvretta Capital (1,481,481 shares of common stock) Use of proceeds: Continued development of product candidate programs, working capital and general corporate purposes | Nov 6, 2025 |
| Public offering of common stock or pre-funded warrants Announced: US$13 a share · Leerink Partners +2 Dealers: Leerink Partners (co-lead), TD Cowen (co-lead), Citizens Capital Markets Use of proceeds: Continued development of product candidate programs, working capital and general corporate purposes | Mar 25, 2025 |
| Registered direct offering of common stock Announced: US$13 a share Buyers: Suvretta Capital (900,000 shares of common stock) Use of proceeds: Continued development of product candidate programs, working capital and general corporate purposes | Mar 25, 2025 |